跳转至内容
Merck

P57204

Sigma-Aldrich

哒嗪

98%

别名:

1,2-二氮杂苯, 1,2-噻嗪, 邻噻嗪

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C4H4N2
CAS号:
分子量:
80.09
Beilstein:
103906
EC號碼:
MDL號碼:
分類程式碼代碼:
12352100
PubChem物質ID:
NACRES:
NA.22

化驗

98%

折射率

n20/D 1.524 (lit.)

bp

208 °C (lit.)

mp

−8 °C (lit.)

密度

1.103 g/mL at 25 °C (lit.)

SMILES 字串

c1ccnnc1

InChI

1S/C4H4N2/c1-2-4-6-5-3-1/h1-4H

InChI 密鑰

PBMFSQRYOILNGV-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

哒嗪是一种单碱式1,2-二嗪化合物,通常可通过1,4-二羰基与肼反应进行制备。哒嗪环存在于如克雷达嗪、吡哆醇等多种除草剂,以及如头孢唑仑、奥拉帕利、他拉唑帕利和卡达拉嗪等多种药物中。

應用

哒嗪可用于:
  • 作为构建单元,用于合成可作为GSK-3抑制剂的N-苯基-4-吡唑并[1,5-b]哒嗪-3-基-嘧啶-2-胺衍生物。
  • 作为合成具有重要药用价值的吡咯并[1,2-b]哒嗪衍生物的起始材料。
  • 在酸性条件下制备可作为钢铁缓蚀剂的1-(6-乙氧基-6-氧代己基)哒嗪-1-溴化铵和1-(2-溴乙酰基)哒嗪溴化铵离子液体。

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 3

閃點(°F)

185.0 °F - closed cup

閃點(°C)

85 °C - closed cup

個人防護裝備

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 1

1 of 1

Masaomi Terajima et al.
European journal of pharmacology, 698(1-3), 455-462 (2012-11-28)
Given the key role p38 mitogen-activated protein kinase (MAPK) plays in inflammatory responses through the production of cytokines and inflammatory mediators, its inhibition is considered a promising therapeutic strategy for chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel
Jeffrey R Reimers et al.
Physical chemistry chemical physics : PCCP, 14(25), 8791-8802 (2012-04-26)
A unified picture is presented of water interacting with pyridine, pyridazine, pyrimidine, and pyrazine on the S(1) manifold in both gas-phase dimers and in aqueous solution. As (n,π*) excitation to the S(1) state removes electrons from the ground-state hydrogen bond
Emily A Peterson et al.
Bioorganic & medicinal chemistry letters, 22(15), 4967-4974 (2012-07-07)
mTOR is a critical regulator of cellular signaling downstream of multiple growth factors. The mTOR/PI3K/AKT pathway is frequently mutated in human cancers and is thus an important oncology target. Herein we report the evolution of our program to discover ATP-competitive
Six membered heterocyclic compounds with two or more heteroatoms
Heterocyclic Chemistry (2010)
Alessio Raimondi et al.
Inorganic chemistry, 51(5), 2966-2975 (2012-03-01)
A series of [Re(2)(μ-ER)(2)(CO)(6)(μ-pydz)] complexes have been synthesized (E = S, R = C(6)H(5), 2; E = O, R = C(6)F(5), 3; C(6)H(5), 4; CH(3), and 5; H, 6), starting either from [Re(CO)(5)O(3)SCF(3)] (for 2 and 4), [Re(2)(μ-OR)(3)(CO)(6)](-) (for 3

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门